Presentatio on IPQC for Capsules by Akshay Trivedi
Quality control (QC) is a process by which entities review the quality of all factors involved in production. ISO 9000 defines quality control as "A part of quality management focused on fulfilling quality requirements".[1]
This approach places an emphasis on three aspects (enshrined in standards such as ISO 9001)[2][3]:
Elements such as controls, job management, defined and well managed processes,[4][5] performance and integrity criteria, and identification of records
Competence, such as knowledge, skills, experience, and qualifications
Soft elements, such as personnel, integrity, confidence, organizational culture, motivation, team spirit, and quality relationships.
Inspection is a major component of quality control, where physical product is examined visually (or the end results of a service are analyzed). Product inspectors will be provided with lists and descriptions of unacceptable product defects such as cracks or surface blemishes for example.[3]
The quality of the outputs is at risk if any of these three aspec
Modern humans are distinguished from other species by their extensive use of tools to control and adapt to their surroundings. Early stone tools such as anvils had no holes and were not designed as interchangeable parts. Mass production established processes for the creation of parts and system with identical dimensions and design, but these processes are not uniform and hence some customers were unsatisfied with the result. Quality control separates the act of testing products to uncover defects from the decision to allow or deny product release, which may be determined by fiscal constraints.[6] For contract work, particularly work awarded by government agencies, quality control issues are among the top reasons for not renewing a contract.[7]
The simplest form of quality control was a sketch of the desired item. If the sketch did not match the item, it was rejected, in a simple Go/no go procedure. However, manufacturers soon found it was difficult and costly to make parts be exactly like their depiction; hence around 1840 tolerance limits were introduced, wherein a design would function if its parts were measured to be within the limits. Quality was thus precisely defined using devices such as plug gauges and ring gauges. However, this did not address the problem of defective items; recycling or disposing of the waste adds to the cost of production, as does trying to reduce the defect rate. Various methods have been proposed to prioritize quality control issues and determine whether to leave them unaddressed or use quality assurance techniques to improve and stabilize production.[6]
Notable approaches
This document discusses capsules as a dosage form of medication. It provides an introduction to capsules, describing them as solid dosage forms that contain one or more ingredients enclosed in a gelatin shell. The document outlines the advantages of capsules, such as masking unpleasant tastes and being easy to swallow. Disadvantages include some drugs or solutions being unsuitable for capsules. The document also describes various quality control tests for capsules, such as appearance, size, disintegration testing, weight variation, and content uniformity testing. It provides details on procedures for several of these tests.
IPQC?
Its Need
In-Process Quality Control tests for Tablets
Hardness
Friability
Thickness
Disintegration Time
Weight variation
Content uniformity
Dissolution test
Leakage testing for strip and blister packaging
Hardness, friability, thickness, disintegration, weight variation, content uniformity, and dissolution are important quality control tests conducted on tablets. Hardness ensures tablets can withstand handling and processing, while friability measures how well tablets withstand abrasion. Disintegration tests how long it takes for tablets to break down, and weight variation and content uniformity ensure all tablets contain the intended amount of active drug. Dissolution testing determines how quickly the drug is released from the tablet in the body. Documentation of all quality control test results is necessary.
Ipqc tests for sterile formulations are as follows :
Leakage Test
Clarity Test
pH
Particulate Matter Injection
SterilityTest
Pyrogen Test
Content Uniformity & Weight
Volume Filled
The tests For Sterile products are as per IP, BP & USP
This document discusses the qualification of UV-visible spectrophotometry. It begins by defining qualification as an act or process to ensure something complies with conditions, standards, or requirements. There are four types of qualification: design, installation, operational, and performance. UV-visible spectroscopy is concerned with the ultraviolet and visible regions ranging from 200-780 nm. The document outlines parameters for acceptance procedures and performance qualification of a UV-visible spectrophotometer, including wavelength accuracy, stray light, resolution power, noise, baseline flatness, stability, photometric accuracy, and linearity.
This document provides an overview of the design and operations of a pharmaceutical pilot plant for tablet development. It discusses key considerations for scaling up processes like blending, granulation, milling, compression, and coating from small laboratory batches to production-sized equipment. The primary goal of the pilot plant is to ensure new tablet formulations can be efficiently, economically and consistently reproduced at full production scale. Features like air handling, equipment selection, and process parameters must be optimized during this scale-up to prevent issues like contamination, segregation, non-uniformity and other problems.
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
Capsules come in both hard and soft gelatin shells that enclose solid or liquid medications. Quality control tests are conducted on empty capsules and finished capsules to ensure uniformity of weight, content of active ingredients, and dissolution. Key tests include uniformity of weight, content of active ingredients, and uniformity of content. Acceptance criteria vary slightly between pharmacopeias but generally require less than 10% deviation from the average weight and 90-110% of the average active content. In-process quality checks are also important to monitor production and identify defects.
This document discusses capsules as a dosage form of medication. It provides an introduction to capsules, describing them as solid dosage forms that contain one or more ingredients enclosed in a gelatin shell. The document outlines the advantages of capsules, such as masking unpleasant tastes and being easy to swallow. Disadvantages include some drugs or solutions being unsuitable for capsules. The document also describes various quality control tests for capsules, such as appearance, size, disintegration testing, weight variation, and content uniformity testing. It provides details on procedures for several of these tests.
IPQC?
Its Need
In-Process Quality Control tests for Tablets
Hardness
Friability
Thickness
Disintegration Time
Weight variation
Content uniformity
Dissolution test
Leakage testing for strip and blister packaging
Hardness, friability, thickness, disintegration, weight variation, content uniformity, and dissolution are important quality control tests conducted on tablets. Hardness ensures tablets can withstand handling and processing, while friability measures how well tablets withstand abrasion. Disintegration tests how long it takes for tablets to break down, and weight variation and content uniformity ensure all tablets contain the intended amount of active drug. Dissolution testing determines how quickly the drug is released from the tablet in the body. Documentation of all quality control test results is necessary.
Ipqc tests for sterile formulations are as follows :
Leakage Test
Clarity Test
pH
Particulate Matter Injection
SterilityTest
Pyrogen Test
Content Uniformity & Weight
Volume Filled
The tests For Sterile products are as per IP, BP & USP
This document discusses the qualification of UV-visible spectrophotometry. It begins by defining qualification as an act or process to ensure something complies with conditions, standards, or requirements. There are four types of qualification: design, installation, operational, and performance. UV-visible spectroscopy is concerned with the ultraviolet and visible regions ranging from 200-780 nm. The document outlines parameters for acceptance procedures and performance qualification of a UV-visible spectrophotometer, including wavelength accuracy, stray light, resolution power, noise, baseline flatness, stability, photometric accuracy, and linearity.
This document provides an overview of the design and operations of a pharmaceutical pilot plant for tablet development. It discusses key considerations for scaling up processes like blending, granulation, milling, compression, and coating from small laboratory batches to production-sized equipment. The primary goal of the pilot plant is to ensure new tablet formulations can be efficiently, economically and consistently reproduced at full production scale. Features like air handling, equipment selection, and process parameters must be optimized during this scale-up to prevent issues like contamination, segregation, non-uniformity and other problems.
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
Capsules come in both hard and soft gelatin shells that enclose solid or liquid medications. Quality control tests are conducted on empty capsules and finished capsules to ensure uniformity of weight, content of active ingredients, and dissolution. Key tests include uniformity of weight, content of active ingredients, and uniformity of content. Acceptance criteria vary slightly between pharmacopeias but generally require less than 10% deviation from the average weight and 90-110% of the average active content. In-process quality checks are also important to monitor production and identify defects.
IPQC Tests for capsules As per IP, BP & USPPramod Ramane
IPQC- In Process Quality Control Tests for Capsules are
1. Uniformity Of Content
2. Disintigration Test
3. Weight Variation Test
4. Dissolution Test
The tests are with Acceptance limits/Criteria as per Indian Pharmacopoeia (IP), British Pharmacopoeia (BP) & United States Pharmacopoeia (USP)
This document discusses different types of validation processes that are important in the pharmaceutical industry. It describes:
1) Analytical method validation, which proves that analytical methods used for testing are suitable for their intended purpose. This includes validation of accuracy, precision, repeatability, reproducibility, and other quality attributes.
2) Equipment validation to ensure equipment functions as intended, including installation qualification, operational qualification, design qualification, and performance qualification.
3) Cleaning validation to prevent cross-contamination and ensure cleaning procedures adequately remove residues between product batches.
4) Process validation including prospective, concurrent, retrospective, and re-validation to demonstrate manufacturing processes can consistently produce products meeting specifications.
This document provides an overview of the formulation and development of parenteral products. It discusses the key components including containers, closures, processing, formulation, production facilities, and evaluation methods. The production area is divided into five sections - cleanup, preparation, aseptic, quarantine, and finishing/packaging areas. Parenteral formulations contain active drugs, vehicles, and adjuvants. Finished products undergo sterility, clarity, leakage, pyrogen, and assay testing to ensure quality control.
The pharmaceutical Quality by Design (QbD) is a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based sound science and quality risk management.
This document summarizes various tests conducted on packaging materials, including leakage tests, collapsibility tests, clarity tests of aqueous extracts, water vapor permeability tests, transparency tests, and biological tests. The biological tests examine the effects of packaging extracts on mice and rabbits through injection, skin application, and eye irritation tests to check for any adverse biological activities. Additional tests ensure the packaging can withstand stresses like temperature variations and force without breaking or deteriorating. Overall, the document outlines a series of tests used to evaluate the safety and durability of packaging materials.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
The document discusses guidelines for stability testing from the International Conference on Harmonisation (ICH). It provides an overview of several ICH guidelines related to stability testing of drug substances and products, including guidelines on photostability testing, new dosage forms, bracketing and matrixing designs, and evaluation of stability data. It also summarizes key aspects of conducting stability studies such as selecting representative batches, appropriate container closure systems, testing frequency and storage conditions, and evaluation of results. Stress testing is discussed as a way to validate analytical methods and identify potential degradants.
The document discusses the objectives and guidelines of the International Council for Harmonization (ICH) for stability testing of pharmaceutical products. It provides an overview of the key ICH guidelines for stability testing (Q1A-Q1F) and describes the principles of stability testing including establishing re-test periods and shelf lives. It also discusses the different types of stability testing, protocols, study designs like bracketing and matrixing, and key parameters for evaluation.
The document provides an overview of pre-formulation, which involves determining the physicochemical properties of a drug substance prior to developing a dosage form. It discusses the goals of pre-formulation to formulate an efficacious dosage form with good bioavailability. The protocol involves characterizing the physical, chemical, solubility, stability and compatibility properties of the drug. Key aspects covered include polymorphism, hygroscopicity, particle size, solubility, dissolution, stability in solution and solid state, and compatibility with excipients. The information guides subsequent formulation development.
IPQC and FPQC tests are important quality control steps for creams from raw materials to finished product. Creams are topical semisolid preparations used to deliver drugs to the skin. They can be oil-in-water or water-in-oil emulsions. Evaluation of creams includes tests for physical properties, pH, viscosity, spreadability, irritancy, microbial growth, and preservative efficacy. Creams are packaged in jars or tubes and stored properly to ensure stability.
Quality control for rubber closures & secondary materialkavita bahmani
This document outlines various tests that are conducted on rubber closures and secondary packaging materials like paper and board. It describes the preparation of a solution for rubber closures and then lists different tests like sterility testing, fragmentation testing, self-seal ability, pH testing, light absorption testing, and residue on evaporation. It also provides an overview of 20 different tests that are performed on secondary packaging materials to analyze properties like moisture content, density, tensile strength, tear strength, puncture resistance, stiffness, water absorbency, rub resistance, pH, roughness, brightness, wet burst strength, and more.
This document evaluates different tests performed on capsules, including stability, invariability, disintegration, dissolution, and moisture permeation tests. Stability tests evaluate the integrity of the capsule shell and determine shelf life by testing shell integrity and storage conditions. Invariability tests ensure uniform weight and drug content across capsules using weight variation and content uniformity tests. Disintegration and dissolution tests measure how quickly the capsule shell breaks down and releases its drug in water or simulated gastric fluid. Moisture permeation testing verifies the suitability of packaging for preventing moisture from affecting capsules.
Quality control test for capsule and finish product of capsule are
■ weight variation test
■ Dissolution test
■ Disintegration test
■ moisture permeation test
■ contents uniformity test
■ blooms gelatin strength .
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
The document discusses the manufacturing process of parenteral preparations. It describes parenterals as sterile liquids or solids for injection or implantation. The manufacturing process involves planning, material management, production, quality control testing, filling, and packaging. Production areas are divided into strict zones based on cleanliness. Environmental controls and facility design aim to prevent contamination, with areas for filling, weighing, storage, and administration. Personnel flow and utility locations are also considered for efficiency.
In Process Quality Control Tests (IPQC) for Solid Dosage FromSagar Savale
This document discusses in-process quality control tests that are performed during the manufacturing of solid oral dosage forms such as tablets and capsules. It provides details about common tests like weight variation, hardness, friability, disintegration and dissolution. The tests help to identify any issues during production so that corrective actions can be taken. Specific test methods, acceptance criteria and instruments used for tests are outlined for various types of oral dosage forms including immediate release tablets, sustained release tablets, capsules and suppositories. Maintaining quality during manufacturing is important to deliver consistent drug levels in patients.
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
The document discusses the qualification and validation of various analytical techniques used in pharmaceutical quality control including UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and high performance liquid chromatography (HPLC). It provides details on the design qualifications, installation qualifications, operational qualifications, and performance qualifications required for each technique. The key steps include instrument calibration, determination of accuracy and precision, evaluation of limits, and verification that the instruments are operating as intended over time.
Modified Methylene Blue (MMB) Test ProcedureYasin Engin
This document provides detailed procedures for performing the Modified Methylene Blue (MMB) test to determine the amount of methylene blue adsorbed by aggregate fines. The test involves mixing a sample with methylene blue solution, filtering the mixture, diluting it, and measuring absorbance with a colorimeter. A higher methylene blue value indicates higher clay content, which is undesirable for construction materials. Research has shown a strong correlation between methylene blue value and properties like strength reduction and shrinkage in Portland cement concrete containing clay-contaminated aggregates.
The document provides information on various quality control tests performed during the aseptic processing and manufacturing of different dosage forms including ointments, suspensions, emulsions, powders, and parenterals. Some key tests mentioned are particle size determination, viscosity testing, weight variation, clarity testing, sterility testing, and assays to check for active ingredients and check for uniform drug content. The tests help monitor the quality of products during manufacturing to ensure sterile and stable products are produced.
IPQC Tests for capsules As per IP, BP & USPPramod Ramane
IPQC- In Process Quality Control Tests for Capsules are
1. Uniformity Of Content
2. Disintigration Test
3. Weight Variation Test
4. Dissolution Test
The tests are with Acceptance limits/Criteria as per Indian Pharmacopoeia (IP), British Pharmacopoeia (BP) & United States Pharmacopoeia (USP)
This document discusses different types of validation processes that are important in the pharmaceutical industry. It describes:
1) Analytical method validation, which proves that analytical methods used for testing are suitable for their intended purpose. This includes validation of accuracy, precision, repeatability, reproducibility, and other quality attributes.
2) Equipment validation to ensure equipment functions as intended, including installation qualification, operational qualification, design qualification, and performance qualification.
3) Cleaning validation to prevent cross-contamination and ensure cleaning procedures adequately remove residues between product batches.
4) Process validation including prospective, concurrent, retrospective, and re-validation to demonstrate manufacturing processes can consistently produce products meeting specifications.
This document provides an overview of the formulation and development of parenteral products. It discusses the key components including containers, closures, processing, formulation, production facilities, and evaluation methods. The production area is divided into five sections - cleanup, preparation, aseptic, quarantine, and finishing/packaging areas. Parenteral formulations contain active drugs, vehicles, and adjuvants. Finished products undergo sterility, clarity, leakage, pyrogen, and assay testing to ensure quality control.
The pharmaceutical Quality by Design (QbD) is a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based sound science and quality risk management.
This document summarizes various tests conducted on packaging materials, including leakage tests, collapsibility tests, clarity tests of aqueous extracts, water vapor permeability tests, transparency tests, and biological tests. The biological tests examine the effects of packaging extracts on mice and rabbits through injection, skin application, and eye irritation tests to check for any adverse biological activities. Additional tests ensure the packaging can withstand stresses like temperature variations and force without breaking or deteriorating. Overall, the document outlines a series of tests used to evaluate the safety and durability of packaging materials.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
The document discusses guidelines for stability testing from the International Conference on Harmonisation (ICH). It provides an overview of several ICH guidelines related to stability testing of drug substances and products, including guidelines on photostability testing, new dosage forms, bracketing and matrixing designs, and evaluation of stability data. It also summarizes key aspects of conducting stability studies such as selecting representative batches, appropriate container closure systems, testing frequency and storage conditions, and evaluation of results. Stress testing is discussed as a way to validate analytical methods and identify potential degradants.
The document discusses the objectives and guidelines of the International Council for Harmonization (ICH) for stability testing of pharmaceutical products. It provides an overview of the key ICH guidelines for stability testing (Q1A-Q1F) and describes the principles of stability testing including establishing re-test periods and shelf lives. It also discusses the different types of stability testing, protocols, study designs like bracketing and matrixing, and key parameters for evaluation.
The document provides an overview of pre-formulation, which involves determining the physicochemical properties of a drug substance prior to developing a dosage form. It discusses the goals of pre-formulation to formulate an efficacious dosage form with good bioavailability. The protocol involves characterizing the physical, chemical, solubility, stability and compatibility properties of the drug. Key aspects covered include polymorphism, hygroscopicity, particle size, solubility, dissolution, stability in solution and solid state, and compatibility with excipients. The information guides subsequent formulation development.
IPQC and FPQC tests are important quality control steps for creams from raw materials to finished product. Creams are topical semisolid preparations used to deliver drugs to the skin. They can be oil-in-water or water-in-oil emulsions. Evaluation of creams includes tests for physical properties, pH, viscosity, spreadability, irritancy, microbial growth, and preservative efficacy. Creams are packaged in jars or tubes and stored properly to ensure stability.
Quality control for rubber closures & secondary materialkavita bahmani
This document outlines various tests that are conducted on rubber closures and secondary packaging materials like paper and board. It describes the preparation of a solution for rubber closures and then lists different tests like sterility testing, fragmentation testing, self-seal ability, pH testing, light absorption testing, and residue on evaporation. It also provides an overview of 20 different tests that are performed on secondary packaging materials to analyze properties like moisture content, density, tensile strength, tear strength, puncture resistance, stiffness, water absorbency, rub resistance, pH, roughness, brightness, wet burst strength, and more.
This document evaluates different tests performed on capsules, including stability, invariability, disintegration, dissolution, and moisture permeation tests. Stability tests evaluate the integrity of the capsule shell and determine shelf life by testing shell integrity and storage conditions. Invariability tests ensure uniform weight and drug content across capsules using weight variation and content uniformity tests. Disintegration and dissolution tests measure how quickly the capsule shell breaks down and releases its drug in water or simulated gastric fluid. Moisture permeation testing verifies the suitability of packaging for preventing moisture from affecting capsules.
Quality control test for capsule and finish product of capsule are
■ weight variation test
■ Dissolution test
■ Disintegration test
■ moisture permeation test
■ contents uniformity test
■ blooms gelatin strength .
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
The document discusses the manufacturing process of parenteral preparations. It describes parenterals as sterile liquids or solids for injection or implantation. The manufacturing process involves planning, material management, production, quality control testing, filling, and packaging. Production areas are divided into strict zones based on cleanliness. Environmental controls and facility design aim to prevent contamination, with areas for filling, weighing, storage, and administration. Personnel flow and utility locations are also considered for efficiency.
In Process Quality Control Tests (IPQC) for Solid Dosage FromSagar Savale
This document discusses in-process quality control tests that are performed during the manufacturing of solid oral dosage forms such as tablets and capsules. It provides details about common tests like weight variation, hardness, friability, disintegration and dissolution. The tests help to identify any issues during production so that corrective actions can be taken. Specific test methods, acceptance criteria and instruments used for tests are outlined for various types of oral dosage forms including immediate release tablets, sustained release tablets, capsules and suppositories. Maintaining quality during manufacturing is important to deliver consistent drug levels in patients.
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
The document discusses the qualification and validation of various analytical techniques used in pharmaceutical quality control including UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and high performance liquid chromatography (HPLC). It provides details on the design qualifications, installation qualifications, operational qualifications, and performance qualifications required for each technique. The key steps include instrument calibration, determination of accuracy and precision, evaluation of limits, and verification that the instruments are operating as intended over time.
Modified Methylene Blue (MMB) Test ProcedureYasin Engin
This document provides detailed procedures for performing the Modified Methylene Blue (MMB) test to determine the amount of methylene blue adsorbed by aggregate fines. The test involves mixing a sample with methylene blue solution, filtering the mixture, diluting it, and measuring absorbance with a colorimeter. A higher methylene blue value indicates higher clay content, which is undesirable for construction materials. Research has shown a strong correlation between methylene blue value and properties like strength reduction and shrinkage in Portland cement concrete containing clay-contaminated aggregates.
The document provides information on various quality control tests performed during the aseptic processing and manufacturing of different dosage forms including ointments, suspensions, emulsions, powders, and parenterals. Some key tests mentioned are particle size determination, viscosity testing, weight variation, clarity testing, sterility testing, and assays to check for active ingredients and check for uniform drug content. The tests help monitor the quality of products during manufacturing to ensure sterile and stable products are produced.
This document provides information on aseptic processing and in-process quality control tests for various dosage forms including ointments, suspensions, emulsions, powders, and parenterals. It describes how sterile products are manufactured through aseptic processing to ensure sterility. It also outlines various quality tests done during manufacturing to monitor product quality, such as appearance, viscosity, particle size, moisture content, clarity, pH, and microbial limits.
Non sterile manufacturing process technologyPRANJAY PATIL
This document provides an overview of in-process quality control (IPQC) tests for non-sterile pharmaceutical tablets and capsules. It discusses the importance of IPQC in minimizing errors and enforcing manufacturing standards. Common IPQC tests described for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, discussed tests include content of active ingredients, weight variation, content uniformity, disintegration, and dissolution. A variety of apparatus used in conducting these tests are also outlined.
Non sterile manufacturing process technologyPRANJAY PATIL
This document provides an overview of in-process quality control (IPQC) tests for tablets and capsules during the manufacturing process. It discusses the importance and scope of IPQC, as well as general IPQC tests such as identity, quality, purity, and potency tests. Specific IPQC tests covered for tablets include weight variation, content uniformity, hardness, thickness, friability, dissolution, disintegration, and moisture content. For capsules, content of active ingredients, weight variation, content uniformity, disintegration, dissolution, and moisture permeation are discussed. Various apparatus used to perform these tests are also described.
Industrial Pharmacy, Quality control of tablets.pdfAlishaKhatun4
This document discusses quality control testing for tablets. It begins by defining quality control as procedures taken during manufacturing to ensure a product meets requirements and is reproducible. It then describes various types of quality control tests for tablets, including weight variation, drug content, disintegration, dissolution, thickness, hardness, friability, and organoleptic characteristics. The document provides details on testing procedures and equipment for these analyses. It concludes that quality control of tablets requires various tests to be performed during production and after to ensure product standards are met.
Control including pharmaceutical aspects, physical stability and packing of capsules. Capsules provide advantages such as masking taste and odor, ease of swallowing, and economical production. Quality control tests include physical tests like disintegration, weight variation and chemical tests like dissolution and content uniformity. Capsules are packaged in containers like plastic bottles or blister packs to protect from moisture and ensure stability. Pharmaceutical aspects of capsules include improved dissolution and bioavailability over tablets due to liquid fill formulations, as well as reduced gastric irritation potential.
In process & finished products quality control test of capsuleArpitSuralkar
This document discusses quality control tests for pharmaceutical capsules that are performed during the manufacturing process (IPQC tests) and on finished products (FPQC tests). It provides details on various physical parameters tested by IPQC like temperature, humidity, weight variation. FPQC tests include assays, dissolution testing, stability testing, and ensuring uniform drug content between capsules. The document outlines specific test methods and acceptance criteria from pharmacopeias for tests like disintegration, dissolution and content uniformity. It emphasizes that quality testing helps ensure capsules meet regulatory standards and provides maximum safety for human health.
1. The document discusses in-process quality control (IPQC) and finished product quality control (FPQC) tests for pharmaceutical capsules according to various pharmacopoeias. It describes 12 key tests including appearance, size, assay, content uniformity, dissolution, and stability testing.
2. The tests evaluate physical parameters like temperature, humidity, weight, and disintegration time. They also assess the content of active ingredients and whether capsules meet specifications for content uniformity, dissolution rate, and stability over time.
3. Ensuring quality through comprehensive testing during and after production is important for regulatory compliance and producing safe, effective pharmaceuticals. The various pharmacopoeias have different standards and requirements but collectively
Quality Control Tests Of Capsules dosage form.
1. Weight Variation Test
2. Content Uniformity Test
3. Dissolution Test
4. Disintegration Test
5. Leak Test
This document evaluates various properties of tablets including size, shape, thickness, friability, weight variation, disintegration, and dissolution. It describes common tests used to analyze these properties, including friability testing to measure how easily tablets crumble, weight variation testing to check consistency of tablet weights, disintegration testing using glass tubes in fluid, and dissolution testing using apparatus 1 (basket type) or apparatus 2 (paddle type) to measure how quickly drugs dissolve. The document provides details on procedures, equipment, and standards used for these pharmaceutical quality control tests.
In process stability control test for capsuleJinendra Jain
This document discusses quality control testing for capsules. It describes physical tests like disintegration testing, weight variation testing, and chemical tests like dissolution testing and content uniformity testing. Disintegration testing ensures capsules break down within a specified time in liquid. Weight variation testing checks that capsule weights are consistent. Dissolution testing measures how quickly the active drug is released. Content uniformity testing confirms the amount of drug in each capsule is consistent. These quality control tests are important to ensure capsules meet specifications and perform as intended.
This document discusses in-process quality control (IPQC) for various dosage forms including tablets, capsules, liquids, ointments, and parenterals. It provides details on common IPQC tests for each dosage form, such as hardness testing, friability testing, weight variation, disintegration, and dissolution for tablets. Specific steps in sterility testing and leak testing are also outlined for ensuring the quality of sterile parenteral products during manufacturing. The document emphasizes that IPQC is important to monitor processes, make adjustments to ensure product quality meets specifications, and avoid wasted efforts from non-compliant batches.
This document outlines 8 key tests for evaluating ointments and creams: [1] Physical appearance to check for cracking, changes in viscosity, or microbial growth. [2] Particle size determination under a microscope. [3] Weight variation testing of labeled amounts. [4] Solubility testing in water and alcohol. [5] Viscosity determination using specified methods. [6] Assay of active ingredients within official limits. [7] Microbial contamination testing using inoculation or membrane filtration. [8] Testing for metal particles in ophthalmic ointments under a microscope.
This document discusses quality control and quality assurance tests for different dosage forms including tablets, capsules, and creams. For tablets, common tests include dissolution testing, disintegration testing, friability testing, hardness testing, and weight variation testing. For capsules, important tests are dissolution testing, disintegration time limits, uniformity of mass, and assay of active ingredients. Quality tests for creams include checks for physical appearance, particle size determination, weight variation, solubility, viscosity, microbial contamination, and assay of active ingredients. Standards and specifications from sources like the British Pharmacopoeia, United States Pharmacopoeia, and Remington’s Pharmaceutical Sciences are referenced.
This document discusses various tests used to evaluate pharmaceutical ointments and determine their quality. It describes physical tests like examining appearance, measuring particle size, checking weight variation and testing absorption, penetration and drug release rates. It also covers microbiological tests to check microbial content and preservative efficacy. Specific methods are provided for particle size determination, weight variation testing, and evaluating absorption rate. The document emphasizes that these tests are important to characterize individual drug and excipient properties and how moisture can impact them.
This document discusses quality control tests for suppositories. It describes physical tests like visual examination, uniformity of weight, melting point, and mechanical strength. It also describes chemical tests like dissolution testing and assay of active ingredients. The tests ensure suppositories have consistent appearance, size, structure and drug content from batch to batch.
This document outlines the evaluation parameters and testing procedures for suppositories. Key tests include uniformity of weight, disintegration testing, content uniformity, melting point determination, drug assay, and general appearance. The document provides detailed procedures for each test, including using apparatus like disintegration cylinders, melting point testers, and dissolution equipment to assess qualities like drug release rates. The goal is to ensure suppositories are uniform and meet specifications for attributes like drug content and disintegration time.
This document discusses quality control testing for tablets during the manufacturing process. It outlines in-process quality control (IPQC) tests such as granule properties, powder flow, and dissolution that are conducted during production. Finished product quality control (FPQC) tests after manufacturing include tablet thickness, hardness, friability, weight variation, and disintegration time. The objectives of these tests are to ensure quality, identify errors, and that tablets meet specifications. Limit criteria from different pharmacopeias for many common tests are also reviewed. In conclusion, in-process and finished product testing helps ensure product quality by identifying issues early in manufacturing.
Similar to IPQC for capsule by akshay trivedi (20)
pharmaceutical shrink packaging (foil, plastic pouches, bottle seals, tape seals, breakable seals, sealed tubes)
pharmacy
technology
packaging
covers
plastics
Shrink packaging
Shrink packaging indicates the process in which sheets of transparent plastic film are wrapped around a product to form a solid, weather-resistant packaging layer.
Shrink packaging customarily refers to plastic films which have been pre-heated, stretched and cooled prior to use. This causes their initially randomly scattered molecules to align themselves in rigid structures, creating flat sheets of plastic film.
Shrink-wrap
When the shrink packaging films are applied to the product and re-heated, the molecules revert to their previous non-aligned state. This causes the plastic film to shrink and wrap itself tightly around the form and shape of the product (therefore the name ‘shrink-wrap’).
Stretch-wrap
When shrink packaging is simply stretched and wrapped around the product without being re-heated, it is known as ‘stretch-wrap’.
Benefits of shrink-packaging
Shrink packaging offers a versatile, cost-effective packaging solution for several reasons.
First, the materials used (plastic derivatives) are strong yet flexible, and provide effective protection, as well as making the product tamper-proof.
Second, shrink packaging is transparent, making it suitable for retail and wholesale display, and ideal for general marketing purposes due to its clear surface.
Third, shrink packaging is a relatively inexpensive option and ideal for low-cost packaging solutions.
This document discusses the qualification of dissolution test apparatus and validation of utility systems. It covers the installation qualification, operational qualification, and performance qualification of dissolution test apparatus. This includes procedures, acceptance criteria, and maintenance schedules for qualifying the apparatus. It also summarizes validation test functions and acceptance criteria for key utility systems like plant steam, pure steam, water for injection, and emergency power generators. The goal is to ensure dissolution testing provides reliable and reproducible results for assessing drug release and bioavailability.
intertnational council for harmonization The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a project that brings together the regulatory authorities of Europe, Japan and the United States and experts from the pharmaceutical industry in the three regions to discuss scientific and technical aspects Details of the ICH guidelines for pharmaceutical quality from Q1 to Q12 including stability analysis, evaluation of impurities and quality risk management. ICH (Full form = International Conference on Harmonisation) is a committee that provides the pharmaceutical guidelines for industries.
The document discusses the Common Technical Document (CTD) format, which is used for new drug applications submitted to regulatory agencies in Europe, Japan, and the United States. The CTD format aims to increase harmonization across regions. It is organized into five modules covering administrative information, summaries, quality information, nonclinical study reports, and clinical study reports. An electronic version of the CTD (eCTD) uses XML formatting to improve the submission and review process. The eCTD allows for increased accuracy, reduced costs and time to market, and easier navigation compared to the paper CTD format.
Corrective Actions and Preventive Actions.Corrective Action Preventive Action (CAPA) is a process which investigates and solves problems, identifies causes, takes corrective action and prevents recurrence of the root causes. The ultimate purpose of CAPA is to assure the problem can never be experienced again. Corrective vs. Preventive Action. Quality professionals frequently express confusion as to the difference between corrective and preventive action. A corrective action deals with a nonconformity that has occurred, and a preventive action addresses the potential for a nonconformity to occur.
Presentation on customer focus / customer satisfactioon , customer delight and customer complaints handling. In a sense, customer service attains importance within the context of customer focus. In customer focus, the company puts great emphasis on customer success and customer happiness while customer service is one of the various activities to ensure customer happiness.Make the Effort to Follow-up. Some customer service situations require a follow-up contact. ...
Use Clear Language. It's easy to fall into the trap of using unclear language. ...
Do the Time Zone Math. ...
Anticipate Hidden Needs. ...
Use the Pre-Emptive Acknowledgement. ...
Take the Thank You Letter Challenge. ...
Take Action!
10 Steps to Create a Customer-Focused Culture
Define the culture. If you want to have a customer-centric culture, think about exactly what it should look like. ...
Communicate the culture. ...
Hire the right people. ...
Train your people right. ...
5. Make the training inclusive. ...
Be an example. ...
Empower employees to succeed. ...
Give recognition.
The orientation of an organization toward serving its clients' needs. Having a customer focus is usually a strong contributor to the overall success of a business and involves ensuring that all aspects of the company put its customers' satisfaction first.
Research article discussion and validation of a HPLC method for the simultaneous estimation of amlodipine and telmisartan in pharmaceutical dosage form.
A sensitive and simple reversed-phase high-performance liquid chromatographic method (RP-HPLC) was developed and validated for the simultaneous determination of four α-adrenergic receptor blockers: terazosin (TER), alfuzosin (ALF), tamsulosin (TAM) and doxazosin (DOX) using moxifloxacin (MOX) as an internal standard.
Various development trials were performed for the development of a chromatographic system for the estimation of RSV and EZE in their fixed dosage form. On the basis of their structural formula, the reversed-phase liquid chromatography was selected. ... Various columns were available for RP-HPLC method.
More from Akshay Trivedi , Maliba Pharmacy College (7)
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
Thinking of getting a dog? Be aware that breeds like Pit Bulls, Rottweilers, and German Shepherds can be loyal and dangerous. Proper training and socialization are crucial to preventing aggressive behaviors. Ensure safety by understanding their needs and always supervising interactions. Stay safe, and enjoy your furry friends!
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
How to Build a Module in Odoo 17 Using the Scaffold Method
IPQC for capsule by akshay trivedi
1. IPQC FOR CAPSULE
• PREPARED BY : AKSHAY TRIVEDI
• ENROLLMENT NO. : 201804103910007
• M.PHARM – PQA (1ST SEM)
• MALIBA PHARMACY COLLEGE
• UKA TARSADIYA UNIVERSITY
1
2. WHAT IS IPQC?
IPQC is the activity performed between QC and QA.
It is a planned system to identify the materials,
equipments, processes, and operators; to enforce
the flow of manufacturing and packaging
operations according to the established rules and
particles; to minimize human error to detect the
error if and when it does occur; and to pinpoint the
responsibility to the personnel involved in each
unit operation of the entire process.
2
3. In general, in process control procedures are
usually rapid and simple tests or inspection that are
performed when the manufacturing of the product
batch in process.
During manufacturing process in process materials
should be tested for identity, strength, quality and
purity as appropriate and approved or rejected by
the QC unit during the production process.
3
4. The function of IPQC involves monitoring and if
necessary adaption of the manufacturing process
with a view to comply with pharmacopoeias.
4
5. IPQC TESTS FOR CAPSULES
1. BULK DENSITY AND TAPPED DENSITY
2. POWDER COMPRESSIBILITY
3. ANGLE OF REPOSE
4. PARTICLE SIZE DISTRIBUTION
5. APPEARANCE
6. GEL STRENGTH OF GELATIN
7. VISCOSCITY
8. DIMENSIONS OF HARD GELATIN CAPSULE SHELLS
9. UNIFORMITY OF WEIGHT
10. UNIFORMITY OF CONTENT
11. CONTENT OF ACTIVE INGREDIENTS
12. DISINTEGRATION TEST
13. DISSOLUTION TEST
5
6. BULK DENSITY
the ratio of the mass to the volume
Bulk density is determined by measuring the
volume of a known mass Of powder sample that
has been passed through screen into a graduated
cylinder (Method l) through a volume-measuring
apparatus into a cup (Method II).
6
7. Method I-Measurement in a Graduated'-
cylinder
Procedure-
unless otherwise specified pass a quantity of material
sufficient to complete the test through a 1.00 mm(NO.18)
screen to break up agglomerates that may have formed
during storage into a dry 250 ml cylinder introduce ,without
compacting, approximately 100g of test sample, M weighed
with 0.1% accuracy.
Select a sample mass having an untapped apparent volume
of 150-250ml
A 100 ml cylinder is used for apparent volume between 50
mL and 100mL.
7
8. Carefully level the powder without compacting ,if
necessary and read the unsettled apparent volume
V0 to the nearest graduated unit .
Calculate the bulk density in g per mL by this
formula
Bulk density = Mass of granules
Bulk volume of granules
8
9. TAPPED DENSITY
Tapped density is achieved by mechanically tapping
a measuring cylinder containing a' powder sample.
after observing the initial volume, the cylinder is
mechanically tapped, and volume readings are
taken until little further volume change is observed.
The mechanical tapping is achieved by raising the
cylinder and allowing it to drop under its own
weight a specified distance by either of two
methods as described below.
9
10. METHOD I
Procedure :-
Unless otherwise specified, pass a quantity of
material sufficient to complete the test through a
1.00-mm (No. 18) screen to break up agglomerates
that may have formed during storage Into a dry
250-mL glass graduated cylinder (readable to 2 mL)
weighing 220±44 g and mounted on a holder
weighing 450±10 g introduce, without compacting,
approximately 100 g of test sample (M) weighed
with 0.1% accuracy.
10
11. If it is not possible to use 100 g, the amount of the
test sample may be reduced and the volume of the
cylinder may be modified by using a suitable 100-
mL graduated cylinder (readable to 1 mL) weighing
130± 16 g and mounted on a holder weighing
240±12 g.
The modified test conditions are specified with the
results. Carefully level the powder without
compacting, if necessary , and read the ,unsettled
apparent volume(Vo) ,to the nearest graduated
unit.
11
12. Mechanically tap the cylinder containing the sample by
raising the cylinder and allowing it to drop under its own
weight using a suitable mechanical tapped density ,tester
,that provides a fixed drop of 14 ± 2 mm at a nominal rate of
300 drops per minute.
Unless otherwise specified, tap the cylinder 500 times
initially and measure the tapped, volume (V0), to the
nearest graduated unit. Repeat the, tapping
an additional 750 times and measure the tapped volume
(V0) to the nearest graduated unit.
12
13. If the differences between the two volumes is
less, than 2%, (V0) is the final tapped volume, (Vf )
Repeat in increments of 1250 taps as needed; until
the difference between succeeding measurements
is 'less than 2%.
Calculate the tapped density, in g per mL., by this formula-
= M
Vf
13
14. METHOD 2
as directed under Method 1 except that ,suitable
mechanical tapped density tester that provides a
fixed drop of 3 mm (±10%) at a nominal rate Of
250 drops per minute is used: '.
14
15. POWDER COMPRESSIBILITY
The Compressibility Index. and Hausner’s Ratio are
measures of the propensity of a powder to be compressed.
As such, they are measures of the relative importance of
inter particulate interactions.
In a free-flowing powder, such interactions are generally
less significant, and the bulk and tapped densities will be
closer in value.
For poor flowing materials, there are frequently, greater
interparticle interactions, and a greater difference between
the bulk and tapped densities will be observed. These
differences are reflected in the Compressibility Index and
the Hausner’s Ratio.
15
18. ANGLE OF REPOSE
Definition: It is defined as maximum angle possible
between the surface of a pile of the powder and the
horizontal plane.
Method :Form the angle of repose on a fixed base. Vary
the height of the funnel to carefully build up a
symmetrical cone of powder.
The funnel height should be maintained approximately
2-4 cm from the top of the powder pile as it is being
formed in order to minimize the impact of falling
powder on the tip of the cone.
18
19. Determine the angle of repose by measuring the
height of the cone of powder and calculating the
angle of repose, from the following equation:-
ϴ= tan-1(h/r)
where, ϴ = angle of repose.
h = height of pile.
r = radius of base.
19
21. PARTICLE SIZE DISTRIBUTION
Sieving is one of the oldest methods of classifying
powders and granules by particle size distribution
SIEVING METHODS
LIGHT OBSCURATION PARTICLE COUNT TEST
MICROSCOPIC PARTICLE COUNT TEST
21
22. If the test specimen weight is not given in the
monograph for a particular material, use a test
specimen having, weight between 25 and 100 g,
depending on the bulk density of the material.
22
23. APPEARANCE
Capsules produced on a small or a large scale
should be uniform in appearance.
Visual or electronic inspection should be
undertaken to detect any flaws in the integrity and
appearance of the capsule.
Evidence of physical instability is demonstrated by
gross changes in appearance, including hardening
or softening, swelling, printing mistake or
discoloration of the shell. Defective capsules should
be rejected .
23
24. GEL STRENGTH OF GELATIN
Pipet 105 mL of water at,100 to 15° into a standard Bloom
bottle, add 7.5 g of Gelatin, and stir Allow to stand for 1
hour, then bring to a temperature of 62° in 15 minutes by
placing in a water bath regulated at 65° (the substance may
be swirled several times to aid solution).
Finally mix by inversion, allow to stand for 15 minutes, and
place in a water bath at 10±0.10. Chill, without disturbance,
for 17 hours Determine the gel strength in a Bloom
Gelometer (a device-developed to make this determination
under standardized conditions) .
24
25. VISCOSCITY
Viscosity is a property of liquids that is closely related to the resistance
to flow.
basic unit is the “poise”
Measurement of Viscosity - The usual method for measurement of
viscosity involves the determination of the time required for a given
volume of liquid to flow through a capillary.
Ostwald-Type Viscometer,
Brookfield viscometer,
Rotouisco meter,
Stormer viscometer.
25
26. DIMENTIONS OF HARD GELATINE
CAPSULE SHELLS
Hard Gelatine Capsule Shells normally used for the
incorporation of medicaments are cylindrical in
shape but other shapes are also formed for special
requirements. The shells of the capsules consists of
two prefabricated cylindrical sections, one end of
which is rounded and the other is open
26
28. UNIFORMITY OF WEIGHT
Weigh individually 20 units selected at random or,
for single dose preparations in individual
containers, the contents of 20 units, and calculate
the average weight. Not more than two of the
individual weights deviate from the average weight
by more than the percentage shown in the table
and none deviates by more than twice that
percentage.
28
29. Weigh an intact capsule.
Open it without losing any part of the shell and
remove the contents as completely as possible.
For soft gelatine capsules, wash the shell with a
suitable solvent and keep aside until the odour of
the solvent is not perceptible.
Weigh the shell The difference between the
weighing gives the weight of the contents. Repeat
the procedure with another 19 capsules.
29
30. Hard capsules containing 25 mg or more of a drug
substance contain 25% or more, by weight, of the
dosage unit Of in the case of hard capsules, the
capsule contents, except-that uniformity of other
drug substances present in lesser proportions is
demonstrated by meeting Content Uniformity
Requirements.
30
31. UNIFORMITY OF CONTENT
It is pharmaceutical analysis parameter for the
quality control of capsules. Multiple capsules are
selected at random and a suitable analytical
method is applied to assay the individual content
of the active ingredient in each capsule.
The preparation complies if not more than one
individual content is outside the limits of 85 to
115% of the average content and none is outside
the limits of 75 to 125% of the average content.
INDIAN PHARMACOPOEIA 2010 , VOLUME-1 ,P-192
31
32. The preparation fails to comply with the test if more than
3 individual contents are outside the limits of 85 to 115%
of the average content or if one or more individual
contents are outside the limits of 75 to 125% of the
average content.
Calculation of Acceptance Value Calculate the acceptance
value by the formula: .
|M-X|+ks
32
33. CONTENT OF ACTIVE
INGREDIENT
For this test determine the amount of active ingredient
by the method described in the assay and calculate the
amount of active ingredient per capsule .
The capsule complies with the test if content of active
ingredient lies within the stated range The range is
based on the requirement that 20 capsule, or such
other number indicated in the monograph Where 20
capsule are not available a smaller number not less
than 5 can be used, for this smaller number tolerances
are widened in accordance with given capsule.
33
34. DISINTEGRATION TEST
For the purpose of this test, disintegration does not
imply complete solution of the dosage unit or even
of its active constituent.
Disintegration is defined as that state in which no
residue of the unit under test remains on the
screen of the apparatus or, if a residue remains, it
consists of fragments of disintegrated parts of
capsule shells.
34
35. Method-Unless otherwise stated in the individual monograph,
introduce one tablet or capsule into each tube and, if directed in
the appropriate general monograph, add a disc to each tube.
Suspend the assembly in the beaker containing the specified
liquid and operate the apparatus for the specified time. Remove
the assembly from the liquid. The tablets or capsules pass the
test if all of them have disintegrated.
If 1 or 2 capsules fail to disintegrate, repeat the test on 12
additional capsules; If the capsules adhere to the disc and the
preparation under examination fails to comply, repeat the test
omitting the disc. The preparation complies with the test if all the
capsules in the repeat test disintegrate.
35
40. REFERENACE :-
United States Pharmacopeia Convention. Unite
States Pharmacopoeia 33-National Formulary 28.
USA: Stationery Office; 2010.
Indian Pharmacopoeia Commission. Indian
Pharmacopoeia. 7th ed. Ghaziabad: Indian
Pharmacopoeia Commission; 2010.
40